The first strand transfer reaction of HIV-1 reverse transcription is more efficient in infected cells than in cell-free natural endogenous reverse transcription reactions

Journal of Clinical Virology

Volumn 26, Issue 2, 2003, Pages 229-238

  Hooker, C William ^a,b   Harrich, David ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b National Centre for HIV Virology Research   (Australia)

Author keywords

First strand transfer reaction; HIV 1; Natural endogenous reverse transcription; Reverse transcription

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS DNA;

ARTICLE; BIOASSAY; CELL FREE SYSTEM; CONTROLLED STUDY; DNA STRAND; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VESICULAR STOMATITIS VIRUS; VIRION;

EID: 0037322669     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00121-X     Document Type: Article

References (29)

1. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
2. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature. 226:1970;1209-1211.
3. Bukrinskaya A., Brichacek B., Mann A., Stevenson M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188:1998;2113-2125.
4. Burke E., Dupuy L., Wall C., Barik S. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology. 252:1998;137-148.
5. Burke E., Mahoney N.M., Almo S.C., Barik S. Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J. Virol. 74:2000;669-675.
6. Goncalves J., Korin Y., Zack J., Gabuzda D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:1996;8701-8709.
7. Harrich D., Hsu C., Race E., Gaynor R.B. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:1994;5899-5910.
8. Harrich D., Ulich C., Garcia-Martinez L.F., Gaynor R.B. Tat is required for efficient HIV-1 reverse transcription. Embo J. 16:1997;1224-1235.
9. Hooker C.W., Lott W.B., Harrich D. Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. J. Virol. 75:2001;3095-3104.
10. Isel C., Ehresmann C., Keith G., Ehresmann B., Marquet R. Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J. Mol. Biol. 247:1995;236-250.
11. Jacque J.M., Mann A., Enslen H., Sharova N., Brichacek B., Davis R.J., Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. Embo J. 17:1998;2607-2618.
12. Kavanaugh M., Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int. 49:1996;959-963.
13. Kavanaugh M., Miller D., Zhang W., Law W., Kozak S., Kabat D., Miller A. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. 91:1994;7071-7075.
14. Kiernan R.E., Ono A., Englund G., Freed E.O. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72:1998;4116-4126.
15. Li X., Quan Y., Arts E.J., Li Z., Preston B.D., de Rocquigny H., Roques B.P., Darlix J.L., Kleiman L., Parniak M.A., et al. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. J. Virol. 70:1996;4996-5004.
16. Lori F., di Marzo Veronese F., de Vico A.L., Lusso P., Reitz M.S. Jr, Gallo R.C. Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol. 66:1992;5067-5074.
17. Matlin K., Reggio H., Helenius A., Simons K. Pathway of vesicular stomatitis virus entry leading to infection. J. Mol. Biol. 156:1982;609-631.
18. Priel E., Showalter S., Roberts M., Oroszlan S., Segal S., Aboud M., Blair D. Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. EMBO J. 9:1990;4167-4172.
19. Priel E., Showalter S.D., Blair D.G. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor. AIDS Res. Hum. Retroviruses. 7:1991;65-72.
20. Temin H.M., Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature. 226:1970;1211-1213.
21. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature. 372:1994;363-365.
22. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:1992;4893-4900.
23. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
24. Wu X., Liu H., Xiao H., Conway J.A., Hehl E., Kalpana G.V., Prasad V., Kappes J.C. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73:1999;2126-2135.
25. Zhang H., Zhang Y., Spicer T.P., Abbott L.Z., Abbott M., Poiesz B.J. Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Res. Hum. Retroviruses. 9:1993;1287-1296.
26. Zhang H., Bagasra O., Niikura M., Poiesz B.J., Pomerantz R.J. Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals. J. Virol. 68:1994;7591-7597.
27. Zhang H., Dornadula G., Alur P., Laughlin M.A., Pomerantz R.J. Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc. Natl. Acad. Sci. USA. 93:1996;12519-12524.
28. Zhang H., Dornadula G., Pomerantz R.J. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells. J. Virol. 70:1996;2809-2824.
29. Zhang H., Dornadula G., Wu Y., Havlir D., Richman D.D., Pomerantz R.J. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. J. Virol. 70:1996;628-634.